Cencora Cost of Goods Sold 2010-2024 | COR
Cencora annual/quarterly cost of goods sold history and growth rate from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
- Cencora cost of goods sold for the quarter ending September 30, 2024 was $76.558B, a 14.83% increase year-over-year.
- Cencora cost of goods sold for the twelve months ending September 30, 2024 was $284.049B, a 12.18% increase year-over-year.
- Cencora annual cost of goods sold for 2024 was $284.049B, a 12.18% increase from 2023.
- Cencora annual cost of goods sold for 2023 was $253.214B, a 9.95% increase from 2022.
- Cencora annual cost of goods sold for 2022 was $230.291B, a 11.23% increase from 2021.
| Cencora Annual Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2024 | $284,049 |
| 2023 | $253,214 |
| 2022 | $230,291 |
| 2021 | $207,046 |
| 2020 | $184,702 |
| 2019 | $174,451 |
| 2018 | $163,327 |
| 2017 | $148,598 |
| 2016 | $142,577 |
| 2015 | $132,433 |
| 2014 | $116,587 |
| 2013 | $85,451 |
| 2012 | $75,446 |
| 2011 | $76,237 |
| 2010 | $75,451 |
| 2009 | $69,660 |
| Cencora Quarterly Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2024-09-30 | $76,558 |
| 2024-06-30 | $71,831 |
| 2024-03-31 | $65,876 |
| 2023-12-31 | $69,784 |
| 2023-09-30 | $66,669 |
| 2023-06-30 | $64,682 |
| 2023-03-31 | $61,162 |
| 2022-12-31 | $60,701 |
| 2022-09-30 | $59,189 |
| 2022-06-30 | $58,049 |
| 2022-03-31 | $55,484 |
| 2021-12-31 | $57,568 |
| 2021-09-30 | $56,843 |
| 2021-06-30 | $51,517 |
| 2021-03-31 | $47,621 |
| 2020-12-31 | $51,064 |
| 2020-09-30 | $47,898 |
| 2020-06-30 | $44,141 |
| 2020-03-31 | $46,030 |
| 2019-12-31 | $46,634 |
| 2019-09-30 | $44,453 |
| 2019-06-30 | $44,008 |
| 2019-03-31 | $41,895 |
| 2018-12-31 | $44,095 |
| 2018-09-30 | $42,264 |
| 2018-06-30 | $41,931 |
| 2018-03-31 | $39,778 |
| 2017-12-31 | $39,354 |
| 2017-09-30 | $37,948 |
| 2017-06-30 | $37,627 |
| 2017-03-31 | $35,891 |
| 2016-12-31 | $37,132 |
| 2016-09-30 | $36,436 |
| 2016-06-30 | $35,774 |
| 2016-03-31 | $34,623 |
| 2015-12-31 | $35,744 |
| 2015-09-30 | $34,497 |
| 2015-06-30 | $33,342 |
| 2015-03-31 | $31,757 |
| 2014-12-31 | $32,836 |
| 2014-09-30 | $30,716 |
| 2014-06-30 | $29,656 |
| 2014-03-31 | $27,726 |
| 2013-12-31 | $28,488 |
| 2013-09-30 | $23,901 |
| 2013-06-30 | $21,344 |
| 2013-03-31 | $19,807 |
| 2012-12-31 | $20,399 |
| 2012-09-30 | $18,031 |
| 2012-06-30 | $18,659 |
| 2012-03-31 | $19,029 |
| 2011-12-31 | $19,728 |
| 2011-09-30 | $18,348 |
| 2011-06-30 | $19,507 |
| 2011-03-31 | $19,073 |
| 2010-12-31 | $19,308 |
| 2010-09-30 | $18,977 |
| 2010-06-30 | $19,014 |
| 2010-03-31 | $18,689 |
| 2009-12-31 | $18,772 |
| 2009-09-30 | $18,178 |
| 2009-06-30 | $17,875 |
| 2009-03-31 | $16,759 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $43.795B | $293.959B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $86.660B | 10.75 |
| DiDi Global (DIDIY) | China | $22.310B | 0.00 |
| Natera (NTRA) | United States | $21.076B | 0.00 |
| ICON (ICLR) | Ireland | $17.639B | 15.71 |
| Viatris (VTRS) | United States | $14.992B | 4.62 |
| Avantor (AVTR) | United States | $14.620B | 21.92 |
| Revvity (RVTY) | United States | $13.691B | 23.78 |
| BioMerieux (BMXMF) | France | $12.233B | 0.00 |
| CochLear (CHEOY) | Australia | $12.042B | 0.00 |
| Solventum (SOLV) | United States | $11.564B | 0.00 |
| Doximity (DOCS) | United States | $10.907B | 64.20 |
| Medpace Holdings (MEDP) | United States | $10.659B | 30.03 |
| Charles River Laboratories (CRL) | United States | $9.545B | 18.44 |
| HealthEquity (HQY) | United States | $8.442B | 42.35 |
| Sonic Healthcare (SKHHY) | Australia | $8.258B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.388B | 29.74 |
| Amplifon S.p.A (AMFPF) | Italy | $5.864B | 29.89 |
| Organon (OGN) | United States | $3.850B | 3.88 |
| Sotera Health (SHC) | United States | $3.827B | 20.47 |
| BrightSpring Health Services (BTSG) | United States | $3.065B | 65.18 |
| Surgery Partners (SGRY) | United States | $2.716B | 30.97 |
| Concentras Parent (CON) | United States | $2.623B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.382B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.183B | 0.00 |
| Premier (PINC) | United States | $2.090B | 10.88 |
| Alignment Healthcare (ALHC) | United States | $2.078B | 0.00 |
| PACS (PACS) | United States | $2.009B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.723B | 45.20 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.651B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.641B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.295B | 0.00 | |
| Progyny (PGNY) | United States | $1.253B | 25.36 |
| Embecta (EMBC) | United States | $1.211B | 8.47 |
| Pediatrix Medical (MD) | United States | $1.173B | 11.48 |
| CareDx (CDNA) | United States | $1.150B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.918B | 6.21 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| Agilon Health (AGL) | United States | $0.779B | 0.00 |
| SBC Medicals (SBC) | United States | $0.604B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.549B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.496B | 0.00 |
| DocGo (DCGO) | United States | $0.447B | 16.85 |
| Sonida Senior Living (SNDA) | United States | $0.442B | 0.00 |
| Enhabit (EHAB) | United States | $0.389B | 33.61 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.283B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.274B | 0.00 |
| LifeMD (LFMD) | United States | $0.230B | 0.00 |
| Biodesix (BDSX) | United States | $0.212B | 0.00 |
| MultiPlan (MPLN) | United States | $0.203B | 0.00 |
| Beauty Health (SKIN) | United States | $0.195B | 0.00 |
| Nutex Health (NUTX) | United States | $0.179B | 0.00 |
| ModivCare (MODV) | United States | $0.157B | 8.53 |
| So-Young (SY) | China | $0.099B | 16.74 |
| Ascend Wellness Holdings (AAWH) | United States | $0.078B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 1.59 |
| IceCure Medical (ICCM) | Israel | $0.051B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.049B | 0.00 |
| OncoCyte (OCX) | United States | $0.036B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.024B | 0.00 |
| Oncology Institute (TOI) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| KindlyMD (KDLY) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| NewGenIvf Group (NIVF) | Thailand | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |